Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: PET Clin. 2009 Jan 1;4(1):17–38. doi: 10.1016/j.cpet.2009.04.011

Figure 1.

Figure 1

18F-Galacto-RGD scans of 2 patients with metastases from malignant melanoma and different tracer uptake. (Upper row images) An 89-y-old female patient with metastasis in subcutaneous fat in gluteal area on left side (arrow with dotted line). Tumor can be clearly delineated in CT scan (A), whereas it shows no significant uptake in 18F-Galacto-RGD PET scan (B; 60 min after injection). (Lower row images) A 36-y-old female patient with lymph node metastasis in right groin (arrow). Again, tumor is clearly visualized in CT scan (C) but also shows intense tracer uptake in 18F-Galacto-RGD PET scan (D; 89 min after injection; SUV, 6.8). Reproduced from Beer et al. 139 with permission.